Efficacy of the anticaspase agent zVAD-fmk on post-thaw viability of canine spermatozoa

Abstract

Cryopreservation protocols for gametes are constantly improved with the aim of increasing the post-thaw viability of gametes. It is becoming clear that stress, resulting from cryopreservation, reduces cell numbers by apoptosis. Apoptosis, or programmed cell death, is a gene-activated event that occurs as a normal consequence of development and as a result of cellular stress. Apoptosis is mediated by the family of cysteine-dependent asparate-specific proteases (caspases). The present study was designed to test the hypothesis that addition of an anticaspase (zVAD-fmk) that has inhibitory properties against caspases and apoptosis to semen extenders and to the thaw medium would increase post-thaw viability of canine spermatozoa. Extenders were added in a two-step process. A dose of 100 muM caspase inhibitor was used. Four groups (n = 6 for each) were composed based on the presence or absence of the caspase inhibitor: Group I (control), no caspase inhibitor in the extender or the thaw medium; Group 11, caspase inhibitor in the thaw medium; Group 111, caspase inhibitor in Extender 11; and Group IV, caspase inhibitor in both Extender 11 and the thaw medium. Post-thaw motility, plasma membrane integrity, and acrosome status were investigated. The addition of caspase inhibitor to Extender 11 or to the thaw medium failed to improve the parameters that were studied. The results suggest that this caspase inhibitor may not be beneficial to the post-thaw motility of canine spermatozoa if used at this concentration. (C) 2002 Elsevier Science Inc. All rights reserved

Published in

Theriogenology
2003, volume: 59, number: 7, pages: 1525-1532
Publisher: ELSEVIER SCIENCE INC

SLU Authors

• Linde-Forsberg, Catharina

  • Department of Clinical Sciences, Swedish University of Agricultural Sciences
    

Publication identifier

• DOI: https://doi.org/10.1016/S0093-691X(02)01206-2

Permanent link to this page (URI)

https://res.slu.se/id/publ/820